Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 50 Pancreatic Neoplasms 33 Prostatic Neoplasms 31 Brain Neoplasms 28 Lung Neoplasms 26 Neoplasm Metastasis 24 Melanoma 21 Carcinoma, Hepatocellular 20 Breast Neoplasms 17 Carcinoma, Renal Cell 12 Colorectal Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Neoplasms 9 Small Cell Lung Carcinoma 7 Urinary Bladder Neoplasms 5 Recurrence 5 Head and Neck Neoplasms 5 Glioblastoma 5 Adenocarcinoma of Lung 5 Sarcoma 4 Liver Neoplasms 4 Kidney Neoplasms 4 Uterine Cervical Neoplasms 3 NSCLC 3 Clear-cell metastatic renal cell carcinoma 3 Cholangiocarcinoma 3 Uveal Melanoma 2 Unresectable Locally Recurrent Rectal Cancer 2 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2

Interventions

Gemcitabine 6 130-nm albumin-bound paclitaxel 5 Albumin-Bound Paclitaxel 4 Taxes 3 S 1 (combination) 3 Drug Therapy 2 toripalimab 1 surufatinib 1 paricalcitol 1 nimotuzumab 1 irinotecan sucrosofate 1 gimeracil 1 envafolimab 1 endostar protein 1 camrelizumab 1 cabiralizumab 1 apatinib 1 Tegafur 1 Radiosurgery 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Irinotecan 1 Immunotherapy 1 IMM-101 1 Fluorouracil 1 Endostatins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Pancreatic Cancer × Radiosurgery × Clear all

NCT06422156 2024-05-20

Nim-PC-28

Peking University Third Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡